Basic Information
| RNALocate ID: | RLID-D:11000770 |
| RNA Symbol: | hsa-miR-1295a |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-1295a |
| RNA ID: | miRBase:MIMAT0005885 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID-D:11001684 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1295a | Estrogen-receptor positive breast cancer | MNDR-E-MI-09911 |
| MNDR | hsa-miR-1295a | Estrogen-receptor negative breast cancer | MNDR-E-MI-09912 |
| MNDR | hsa-miR-1295a | Progesterone-receptor positive breast cancer | MNDR-E-MI-09913 |
| MNDR | hsa-miR-1295a | Progesterone-receptor negative breast cancer | MNDR-E-MI-09914 |
| MNDR | hsa-miR-1295a | Her2-receptor positive breast cancer | MNDR-E-MI-09915 |
| MNDR | hsa-miR-1295a | Prostate cancer | MNDR-E-MI-09916 |
| MNDR | hsa-miR-1295a | Chronic lymphocytic leukemia | MNDR-E-MI-09917 |
| MNDR | hsa-miR-1295a | Gastric cancer | MNDR-E-MI-09918 |
| MNDR | hsa-miR-1295a | Lung cancer | MNDR-E-MI-09919 |
| MNDR | hsa-miR-1295a | Parkinson disease | MNDR-E-MI-09920 |
| MNDR | hsa-mir-1295a | Breast cancer | MNDR-E-MI-09921 |
| MNDR | hsa-miR-1295a | Breast cancer | MNDR-E-MI-09922 |
| MNDR | hsa-miR-1295a | Pancreatic cancer | MNDR-E-MI-09923 |
| MNDR | hsa-miR-1295a | Melanoma | MNDR-E-MI-09924 |
| MNDR | hsa-miR-1295a | Carcinoma ductal breast | MNDR-E-MI-09925 |
| MNDR | hsa-miR-1295a | Breast carcinoma | MNDR-E-MI-09926 |
| MNDR | hsa-miR-1295a | Lung adenocarcinoma | MNDR-E-MI-09927 |
| MNDR | hsa-miR-1295a | Kidney renal clear cell carcinoma | MNDR-E-MI-09928 |
| MNDR | hsa-miR-1295a | Kidney renal papillary cell carcinoma | MNDR-E-MI-09929 |
| MNDR | hsa-miR-1295a | Renal clear cell carcinoma | MNDR-E-MI-09930 |
| MNDR | hsa-miR-1295a | Cholangiocarcinoma | MNDR-E-MI-09931 |
| MNDR | hsa-miR-1295a | Stomach carcinoma | MNDR-E-MI-09932 |
| MNDR | hsa-miR-1295a | Breast invasive carcinoma | MNDR-E-MI-09933 |
| MNDR | hsa-miR-1295a | Hepatocellular carcinoma | MNDR-E-MI-09934 |
| MNDR | hsa-miR-1295a | B-cell lymphoma | MNDR-E-MI-09935 |
| MNDR | hsa-miR-1295a | Hodgkin lymphoma | MNDR-E-MI-09936 |
| MNDR | hsa-miR-1295a | Colorectal cancer | MNDR-E-MI-09937 |
| MNDR | hsa-miR-1295a | Nasopharynx carcinoma | MNDR-E-MI-09938 |
| MNDR | hsa-miR-1295a | Nasopharyngeal cancer | MNDR-E-MI-09939 |
| MNDR | hsa-miR-1295a | Breast cancer her3+ negative | MNDR-E-MI-09940 |
TOP